A theoretical model of financial burden after cancer diagnosis

Papers of special note have been highlighted as: •• of considerable interest

References

• 1. Financial Toxicity and Cancer Treatment. (PDQ®) – Health Professional Version. Institute, NC, MD, USA (2017). www.cancer.gov/about-cancer/managing-care/track-care-costs/financial-toxicity-hp-pdq •• Summarizes research on financial burden in the USA.
  Google Scholar
• 2. Tangka FK, Trogdon JG, Richardson LC, Howard D, Sabatino SA, Finkelstein EA. Cancer treatment cost in the United States: has the burden shifted over time? Cancer 116(14), 3477–3484 (2010).
  MedlineGoogle Scholar
• 3. Khera N, Chang YH, Hashmi S et al. Financial burden in recipients of allogeneic hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 20(9), 1375–1381 (2014).
  MedlineGoogle Scholar
• 4. Yabroff KR, Dowling EC, Guy GP et al. Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J. Clin. Oncol. 34(3), 259–267 (2016).
  MedlineGoogle Scholar
• 5. Kale HP, Carroll NV. Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors. Cancer 122(8), 283–289 (2016).
  MedlineGoogle Scholar
• 6. Jagsi R, Pottow JA, Griffith KA et al. Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J. Clin. Oncol. 32(12), 1269–1276 (2014).
  MedlineGoogle Scholar
• 7. Huntington SF, Weiss BM, Vogl DT et al. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Haematol. 2(10), e408–416 (2015).
  MedlineGoogle Scholar
• 8. de Souza JA, Yap BJ, Wroblewski K et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer 123(3), 476–484 (2017).
  MedlineGoogle Scholar
• 9. Bestvina CM, Zullig LL, Rushing C et al. Patient-oncologist cost communication, financial distress, and medication adherence. J. Oncol. Pract. 10(3), 162–167 (2014).
  MedlineGoogle Scholar
• 10. Sharp L, Carsin AE, Timmons A. Associations between cancer-related financial stress and strain and psychological well-being among individuals living with cancer. Psychooncology 22(4), 745–755 (2013).
  MedlineGoogle Scholar
• 11. Ell K, Xie B, Wells A, Nedjat-Haiem F, Lee PJ, Vourlekis B. Economic stress among low-income women with cancer: effects on quality of life. Cancer 112(3), 616–625 (2008).
  MedlineGoogle Scholar
• 12. Fenn KM, Evans SB, McCorkle R et al. Impact of financial burden of cancer on survivors' quality of life. J. Oncol. Pract. 10(5), 332–338 (2014).
  MedlineGoogle Scholar
• 13. Hamilton JG, Wu LM, Austin JE et al. Economic survivorship stress is associated with poor health-related quality of life among distressed survivors of hematopoietic stem cell transplantation. Psychooncology 22(4), 911–921 (2013).
  MedlineGoogle Scholar
• 14. Lathan CS, Cronin A, Tucker-Seeley R, Zafar SY, Ayanian JZ, Schrag D. Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer. J. Clin. Oncol. 34(15), 1732–1740 (2016).
  Medline CASGoogle Scholar
• 15. Park J, Look KA. Relationship between objective financial burden and the health-related quality of life and mental health of patients with cancer. J. Oncol. Pract. 14(2), e113–e121 (2018).
  MedlineGoogle Scholar
• 16. Zafar SY, Abernethy AP. Financial toxicity, part I: a new name for a growing problem. Oncology 27(2), 80–149 (2013).
  MedlineGoogle Scholar
• 17. Smith GL, Lopez-Olivo MA, Advani PG et al. Financial burdens of cancer treatment: a systematic review of risk factors and outcomes. J. Natl. Compr. Canc. Netw. 17(10), 1184–1192 (2019).
  MedlineGoogle Scholar
• 18. Ramsey SD, Bansal A, Fedorenko CR et al. Financial insolvency as a risk factor for early mortality among patients with cancer. J. Clin. Oncol. 34(9), 980–986 (2016). •• Links financial burden to mortality.
  Medline CASGoogle Scholar
• 19. Zafar SY, Abernethy AP. Financial toxicity, part II: how can we help with the burden of treatment-related costs? Oncology 27(4), 253–254(2013).
  MedlineGoogle Scholar
• 20. Henrikson NB, Tuzzio L, Loggers ET, Miyoshi J, Buist DS. Patient and oncologist discussions about cancer care costs. Support. Care Cancer 22(4), 961–967 (2014).
  MedlineGoogle Scholar
• 21. Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR. Financial hardships experienced by cancer survivors: a systematic review. J. Natl Cancer Inst. 109 (2), djw205 (.2017). •• Systematic review of financial burden.
  MedlineGoogle Scholar
• 22. Gordon LG, Merollini KMD, Lowe A, Chan RJ. A systematic review of financial toxicity among cancer survivors: we can't pay the co-pay. Patient 10(3), 295–309 (2017). •• Systematic review of financial burden.
  MedlineGoogle Scholar
• 23. Francoeur RB. Cumulative financial stress and strain in palliative radiation outpatients: the role of age and disability. Acta Oncol. 44(4), 369–381 (2005). •• Descriptive model of financial burden.
  MedlineGoogle Scholar
• 24. Carrera PM, Kantarjian HM, Blinder VS. The financial burden and distress of patients with cancer: understanding and stepping-up action on the financial toxicity of cancer treatment. CA Cancer J. Clin. 68(2), 153–165 (2018).
  MedlineGoogle Scholar
• 25. Dobkin C, Finkelstein A, Kluender R, Notowidigdo MJ. The economic consequences of hospital admissions. Am. Econ. Rev. 102(2), 308–352 (2018).
  MedlineGoogle Scholar
• 26. Beck AT, Haigh EA. Advances in cognitive theory and therapy: the generic cognitive model. Annu. Rev. Clin. Psychol. 10, 1–24 (2014).
  MedlineGoogle Scholar
• 27. Bandura A. Social cognitive theory: an agentic perspective. Annu. Rev. Psychol. 52, 1–26 (2001).
  Medline CASGoogle Scholar
• 28. Halbesleben JRB, Neveu J-P, Paustian-Underdahl SC, Westman M. Getting to the ‘COR’: understanding the role of resources in conservation of resources theory. J. Manage. 40(5), 1334–1364 (2014). •• Summarizes conservation of resources theory and related research.
  Google Scholar
• 29. Hanly P, Maguire R, Ceilleachair AO, Sharp L. Financial hardship associated with colorectal cancer survivorship: the role of asset depletion and debt accumulation. Psychooncology 27(9), 2165–2171 (2018).
  MedlineGoogle Scholar
• 30. Tucker-Seeley RD, Yabroff KR. Minimizing the ‘financial toxicity’associated with cancer care: advancing the research agenda. J. Natl Cancer Inst. 108 (.5), djv410 (2016).
  MedlineGoogle Scholar
• 31. Neumann P, Sanders G, Russell L, Siegel J, Ganiats T. Cost-Effectiveness in Health and Medicine Oxford University Press, Oxford, UK, 536 (2016). •• Findings of the second panel on cost-effectiveness research.
  Google Scholar
• 32. Carias C, Chesson HW, Grosse SD et al. Recommendations of the second panel on cost effectiveness in health and medicine: a reference, not a rule book. Am. J. Prev. Med. 54(4), 600–602 (2018).
  MedlineGoogle Scholar
• 33. Azzani M, Roslani AC, Su TT. The perceived cancer-related financial hardship among patients and their families: a systematic review. Support. Care Cancer 23(3), 889–898 (2015).
  MedlineGoogle Scholar
• 34. Chirikos TN, Russell-Jacobs A, Cantor AB. Indirect economic effects of long-term breast cancer survival. Cancer Pract. 10(5), 248–255 (2002).
  MedlineGoogle Scholar
• 35. Longo CJ, Deber R, Fitch M, Williams AP, D'Souza D. An examination of cancer patients’ monthly ‘out-of-pocket’ costs in Ontario, Canada. Eur. J. Cancer Care 16(6), 500–507 (2007).
  Medline CASGoogle Scholar
• 36. Lauzier S, Levesque P, Drolet M et al. Out-of-pocket costs for accessing adjuvant radiotherapy among Canadian women with breast cancer. J. Clin. Oncol. 29(30), 4007–4013 (2011).
  MedlineGoogle Scholar
• 37. Housser E, Mathews M, Lemessurier J, Young S, Hawboldt J, West R. Responses by breast and prostate cancer patients to out-of-pocket costs in Newfoundland and Labrador. Curr. Oncol. 20(3), 158–165 (2013).
  Medline CASGoogle Scholar
• 38. de Oliveira C, Bremner KE, Ni A, Alibhai SM, Laporte A, Krahn MD. Patient time and out-of-pocket costs for long-term prostate cancer survivors in Ontario, Canada. J. Cancer Surviv. 8(1), 9–20 (2014).
  MedlineGoogle Scholar
• 39. Lauzier S, Maunsell E, Drolet M et al. Wage losses in the year after breast cancer: extent and determinants among Canadian women. J. Natl Cancer Inst. 100(5), 321–332 (2008).
  MedlineGoogle Scholar
• 40. Mojahedian MM, Toroski M, Keshavarz K, Aghili M, Zeyghami S, Nikfar S. Estimating the cost of illness of prostate cancer in Iran. Clin. Ther. 41(1), 50–58 (2019).
  MedlineGoogle Scholar
• 41. Longo CJ, Fitch M, Deber RB, Williams AP. Financial and family burden associated with cancer treatment in Ontario, Canada. Support. Care Cancer 14(11), 1077–1085 (2006).
  MedlineGoogle Scholar
• 42. Baird KE. Recent trends in the probability of high out-of-pocket medical expenses in the United States. SAGE Open Med. 4, doi: 10.1177/2050312116660329 (2016).
  Google Scholar
• 43. Hazell SZ, Fu W, Hu C et al. Financial toxicity in lung cancer: an assessment of magnitude, perception, and impact on quality of life. Ann. Oncol. 31(1), 96–102 (2020).
  Medline CASGoogle Scholar
• 44. Nekhlyudov L, Walker R, Ziebell R, Rabin B, Nutt S, Chubak J. Cancer survivors’ experiences with insurance, finances, and employment: results from a multisite study. J. Cancer Surviv. 10(6), 1104–1111 (2016).
  MedlineGoogle Scholar
• 45. Wheeler SB, Spencer J, Pinheiro LC, Carey LA, Olshan AF, Reeder-Hayes KE. Racial differences in the financial impact of breast cancer. J. Clin. Oncol. 35(Suppl. 15), e18293 (2017).
  Google Scholar
• 46. Weaver KE, Geiger AM, Lu L, Case LD. Rural-urban disparities in health status among US cancer survivors. Cancer 119(5), 1050–1057 (2013).
  MedlineGoogle Scholar
• 47. George N, Grant R, James A, Mir N, Politi MC. Burden associated with selecting and using health insurance to manage care costs: results of a qualitative study of nonelderly cancer survivors. Med. Care Res. Rev. doi: 10.1177/1077558718820232 (2018).
  MedlineGoogle Scholar
• 48. Imber BS, Varghese M, Ehdaie B, Gorovets D. Financial toxicity associated with treatment of localized prostate cancer. Nat. Rev. Urol. 17(1), 28–40 (2020).
  MedlineGoogle Scholar
• 49. Jones SMW, Chennupati S, Nguyen T, Fedorenko C, Ramsey SD. Comorbidity is associated with higher risk of financial burden in Medicare beneficiaries with cancer but not heart disease or diabetes. Medicine (Baltimore) 98(1), e14004 (2019).
  MedlineGoogle Scholar
• 50. Stanislawski K. The coping circumplex model: an integrative model of the structure of coping with stress. Front. Psychol. 10, 694 (2019).
  MedlineGoogle Scholar
• 51. Ehring T, Watkins ER. Repetitive negative thinking as a transdiagnostic process. Int. J. Cogn. Ther. 1(3), 192–205 (2008).
  Google Scholar
• 52. Jones SMW, Walker R, Fujii M, Nekhlyudov L, Rabin BA, Chubak J. Financial difficulty, worry about affording care, and benefit finding in long-term survivors of cancer. Psychooncology 27(4), 1320–1326 (2018).
  MedlineGoogle Scholar
• 53. Carney CE, Harris AL, Moss TG, Edinger JD. Distinguishing rumination from worry in clinical insomnia. Behav. Res. Ther. 48(6), 540–546 (2010).
  MedlineGoogle Scholar
• 54. Ciesla JA, Dickson KS, Anderson NL, Neal DJ. Negative repetitive thought and college drinking: angry rumination, depressive rumination, co-rumination, and worry. Cognit. Ther. Res. 35, 142–150 (2011).
  Google Scholar
• 55. Aldao A, Mennin DS, McLaughlin KA. Differentiating worry and rumination: evidence from heart rate variability during spontaneous regulation. Cognit. Ther. Res. 37(3), 613–619 (2013).
  MedlineGoogle Scholar
• 56. Lewis EJ, Yoon KL, Joormann J. Emotion regulation and biological stress responding: associations with worry, rumination, and reappraisal. Cogn. Emot. 1–12 (2017).
  MedlineGoogle Scholar
• 57. Hong RY. Worry and rumination: differential associations with anxious and depressive symptoms and coping behavior. Behav. Res. Ther. 45(2), 277–290 (2007).
  MedlineGoogle Scholar
• 58. Crowley MJ, Zullig LL, Shah BR et al. Medication non-adherence after myocardial infarction: an exploration of modifying factors. J. Gen. Intern. Med. 30(1), 83–90 (2015).
  MedlineGoogle Scholar
• 59. Shapiro GK, Burchell BJ. Measuring financial anxiety. J. Neurosci. Psychol. Econ. 5(2), 92–103 (2012).
  Google Scholar
• 60. Dusetzina SB, Winn AN, Abel GA, Huskamp HA, Keating NL. Cost sharing and adherence to tyrosine kinase inhibitors for patients with chronic myeloid leukemia. J. Clin. Oncol. 32(4), 306–311 (2014).
  MedlineGoogle Scholar
• 61. Kaisaeng N, Harpe SE, Carroll NV. Out-of-pocket costs and oral cancer medication discontinuation in the elderly. J. Manage. Care Spec. Pharm. 20(7), 669–675 (2014).
  MedlineGoogle Scholar
• 62. Jerndal P, Ringstrom G, Agerforz P et al. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS. Neurogastroenterol. Motil. 22(6), 646–e179 (2010).
  Medline CASGoogle Scholar
• 63. Buss C, Davis EP, Hobel CJ, Sandman CA. Maternal pregnancy-specific anxiety is associated with child executive function at 6–9 years age. Stress 14(6), 665–676 (2011).
  Medline CASGoogle Scholar
• 64. Bronfenbrenner U. Ecological systems theory. In: Annals of Child Development. Vasta R (Ed.). Jessica Kingsley Publishers, London, UK, 6, 187–249(1989).
  Google Scholar
• 65. Jones SMW, Nguyen T, Chennupati S. Association of financial burden with self-rated and mental health in older adults with cancer. J. Aging Health 32(5-6) 394–400 (2019).
  MedlineGoogle Scholar
• 66. Hershman DL, Shao T, Kushi LH et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res. Treat. 126(2), 529–537 (2011).
  Medline CASGoogle Scholar
• 67. Adrion ER, Ryan AM, Seltzer AC, Chen LM, Ayanian JZ, Nallamothu BK. Out-of-pocket spending for hospitalizations among nonelderly adults. JAMA Intern. Med. 176(9), 1325–1332 (2016).
  MedlineGoogle Scholar
• 68. Majhail NS, Mau LW, Denzen EM, Arneson TJ. Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large national private claims database. Bone Marrow Transplant. 48(2), 294–300 (2013).
  Medline CASGoogle Scholar
• 69. Majhail NS, Rizzo JD, Hahn T et al. Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 48(6), 865–871 (2013).
  Medline CASGoogle Scholar
• 70. Agency for Health care Research and Quality. Medical Expenditure Panel Survey. MD, USA (2014).
  Google Scholar
• 71. Lauzier S, Maunsell E, Drolet M, Coyle D, Hebert-Croteau N. Validity of information obtained from a method for estimating cancer costs from the perspective of patients and caregivers. Qual. Life Res. 19(2), 177–189 (2010).
  MedlineGoogle Scholar
• 72. Washington State Department of Health. Guidelines for using rural-urban classification systems for community health assessment. Health Olympia, WA, USA (2016).
  Google Scholar
• 73. Paez KA, Mallery CJ, Noel H et al. Development of the Health Insurance Literacy Measure (HILM): conceptualizing and measuring consumer ability to choose and use private health insurance. J. Health Commun. 19(Suppl. 2), 225–239 (2014).
  MedlineGoogle Scholar
• 74. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J. Clin. Epidemiol. 47(11), 1245–1251 (1994).
  Medline CASGoogle Scholar
• 75. Consumer Financial Protection Bureau. Measuring financial well-being: a guide to using the CFPB Financial Well-Being Scale. Bureau, CFP Consumer Financial Protection Bureau, Washington, DC (2015).
  Google Scholar
• 76. Archuleta KL, Dale A, Spann SM. College students and financial distress: exploring debt, financial satisfaction, and financial anxiety. J. Financial Couns. Plan. 24(2), 50–62 (2013).
  Google Scholar
• 77. Prawitz AD, Garman ET, Sorhaindo B, O'Neill B, Kim J, Drentea P. InCharge financial distress/financial well-being scale: development, administration, and score interpretation. Financial Couns. Plan. 17(1), 34–50 (2006).
  Google Scholar
• 78. Syrjala KL, Yi JC, Langer SL. Psychometric properties of the Cancer and Treatment Distress (CTXD) measure in hematopoietic cell transplantation patients. Psychooncology 25(5), 529–535 (2016).
  MedlineGoogle Scholar
• 79. Jones SMW, Amtmann D. Health care worry is associated with worse outcomes in multiple sclerosis. Rehabil. Psychol. 59(3), 354–359 (2014).
  MedlineGoogle Scholar
• 80. Jones SM, Amtmann D. Differential item function analysis of a scale measuring worry about affording healthcare in multiple sclerosis. Rehabil. Psychol. 61(4), 430–434 (2016).
  MedlineGoogle Scholar
• 81. Veenstra CM, Regenbogen SE, Hawley ST et al. A composite measure of personal financial burden among patients with stage III colorectal cancer. Med. Care 52(11), 957–962 (2014).
  MedlineGoogle Scholar
• 82. National Center for Health Statistics. Survey Description, National Health Interview Survey, 2017. Statistics, NCfH Centers for Disease Control and Prevention, MD, USA (2018).
  Google Scholar
• 83. Wiggins R. Financial Wellness Continuum. (2019). www.afcpe.org/news-and-publications/blog/working-together-to-strengthen-the-continuum-of-care/
  Google Scholar
• 84. Shankaran V, Leahy T, Steelquist J et al. Pilot feasibility study of an oncology financial navigation program. J. Oncol. Pract. 14(2), e122–e129 (2018).
  MedlineGoogle Scholar
• 85. Greenbaum Z. Pathways for addressing deep poverty. Monitor Psychol. 50(7), 32 (2019).
  Google Scholar